353 related articles for article (PubMed ID: 9182675)
1. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice.
Pascolo S; Bervas N; Ure JM; Smith AG; Lemonnier FA; Pérarnau B
J Exp Med; 1997 Jun; 185(12):2043-51. PubMed ID: 9182675
[TBL] [Abstract][Full Text] [Related]
2. Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain.
Carmon L; El-Shami KM; Paz A; Pascolo S; Tzehoval E; Tirosh B; Koren R; Feldman M; Fridkin M; Lemonnier FA; Eisenbach L
Int J Cancer; 2000 Feb; 85(3):391-7. PubMed ID: 10652432
[TBL] [Abstract][Full Text] [Related]
3. Phenotypical and functional characterization of the CD8+ T cell repertoire of HLA-A2.1 transgenic, H-2KbnullDbnull double knockout mice.
Ureta-Vidal A; Firat H; Pérarnau B; Lemonnier FA
J Immunol; 1999 Sep; 163(5):2555-60. PubMed ID: 10452993
[TBL] [Abstract][Full Text] [Related]
4. Generation of a Novel HLA Class I Transgenic Mouse Model Carrying a Knock-in Mutation at the β2-Microglobulin Locus.
Harada N; Fukaya S; Wada H; Goto R; Osada T; Gomori A; Ikizawa K; Sakuragi M; Oda N
J Immunol; 2017 Jan; 198(1):516-527. PubMed ID: 27881704
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice.
Firat H; Cochet M; Rohrlich PS; Garcia-Pons F; Darche S; Danos O; Lemonnier FA; Langlade-Demoyen P
Int Immunol; 2002 Aug; 14(8):925-34. PubMed ID: 12147629
[TBL] [Abstract][Full Text] [Related]
6. Expression of H-2Db on the cell surface in the absence of detectable beta 2 microglobulin.
Potter TA; Boyer C; Verhulst AM; Golstein P; Rajan TV
J Exp Med; 1984 Jul; 160(1):317-22. PubMed ID: 6376684
[TBL] [Abstract][Full Text] [Related]
7. Identification of Mycobacterium tuberculosis CTL epitopes restricted by HLA-A*0201 in HHD mice.
Rafiei A; Kiutade Y
Iran Biomed J; 2007 Jan; 11(1):23-31. PubMed ID: 18051701
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of HLA-A2.1 in transgenic mice.
Epstein H; Hardy R; May JS; Johnson MH; Holmes N
Eur J Immunol; 1989 Sep; 19(9):1575-83. PubMed ID: 2676561
[TBL] [Abstract][Full Text] [Related]
9. Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice.
Tammiruusu A; Haveri A; Pascolo S; Lahesmaa R; Stevanovic S; Rammensee HG; Sarvas M; Puolakkainen M; Vuola JM
Scand J Immunol; 2005 Aug; 62(2):131-9. PubMed ID: 16101819
[TBL] [Abstract][Full Text] [Related]
10. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice.
Pacasova R; Martinozzi S; Boulouis HJ; Ulbrecht M; Vieville JC; Sigaux F; Weiss EH; Pla M
J Immunol; 1999 May; 162(9):5190-6. PubMed ID: 10227992
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8+ T-cell responses in HLA-A2.1/Kb transgenic mice.
Zhang Y; Li S; Shan M; Pan X; Zhuang K; He L; Gould K; Tien P
Immunology; 2007 May; 121(1):105-12. PubMed ID: 17244158
[TBL] [Abstract][Full Text] [Related]
12. A chimeric HLA-A2:β2M:Ig fusion protein for the study of virus-specific CD8
Ribeiro ÁL; Araújo FP; Martins JP; Lourenço AA; Huang J; Pereira FV; Andrade LAF; Paim AAO; da Fonseca FG; Barbosa-Stancioli EF; Martins-Filho OA; Peruhype-Magalhães V; Tsuji M; Coelho-Dos-Reis JG
J Immunol Methods; 2021 May; 492():112997. PubMed ID: 33600818
[TBL] [Abstract][Full Text] [Related]
13. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
Snyder JT; Belyakov IM; Dzutsev A; Lemonnier F; Berzofsky JA
J Virol; 2004 Jul; 78(13):7052-60. PubMed ID: 15194781
[TBL] [Abstract][Full Text] [Related]
14. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Xiang J
Vaccine; 2012 May; 30(24):3519-25. PubMed ID: 22484292
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocyte recognition of HLA-A2 antigens in normal and HLA-Cw3-transgenic mice.
Hämmerling GJ; Hunt T; Dill O; Moreno J
Eur J Immunol; 1989 Apr; 19(4):599-604. PubMed ID: 2786469
[TBL] [Abstract][Full Text] [Related]
16. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules.
Newberg MH; Smith DH; Haertel SB; Vining DR; Lacy E; Engelhard VH
J Immunol; 1996 Apr; 156(7):2473-80. PubMed ID: 8786307
[TBL] [Abstract][Full Text] [Related]
17. H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies.
Firat H; Garcia-Pons F; Tourdot S; Pascolo S; Scardino A; Garcia Z; Michel ML; Jack RW; Jung G; Kosmatopoulos K; Mateo L; Suhrbier A; Lemonnier FA; Langlade-Demoyen P
Eur J Immunol; 1999 Oct; 29(10):3112-21. PubMed ID: 10540322
[TBL] [Abstract][Full Text] [Related]
18. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein.
Engelhard VH; Lacy E; Ridge JP
J Immunol; 1991 Feb; 146(4):1226-32. PubMed ID: 1704033
[TBL] [Abstract][Full Text] [Related]
19. Induction in transgenic mice of HLA-A2.1-restricted cytotoxic T cells specific for a peptide sequence from a mutated p21ras protein.
Escobar P; Yu Z; Terskikh A; Holmes N; Corradin G; Mach JP; Healy F
Clin Exp Immunol; 1999 May; 116(2):214-9. PubMed ID: 10337009
[TBL] [Abstract][Full Text] [Related]
20. A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses.
Conforti A; Peruzzi D; Giannetti P; Biondo A; Ciliberto G; La Monica N; Aurisicchio L
J Immunother; 2009 Sep; 32(7):744-54. PubMed ID: 19561534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
